table of content
1 Study Coverage
1.1 Psoriatic Arthritis Drugs Product Introduction
1.2 Global Psoriatic Arthritis Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Psoriatic Arthritis Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Psoriatic Arthritis Drugs Sales in Volume for the Year 2017-2028
1.3 United States Psoriatic Arthritis Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Psoriatic Arthritis Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Psoriatic Arthritis Drugs Sales in Volume for the Year 2017-2028
1.4 Psoriatic Arthritis Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Psoriatic Arthritis Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Psoriatic Arthritis Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Psoriatic Arthritis Drugs Market Dynamics
1.5.1 Psoriatic Arthritis Drugs Industry Trends
1.5.2 Psoriatic Arthritis Drugs Market Drivers
1.5.3 Psoriatic Arthritis Drugs Market Challenges
1.5.4 Psoriatic Arthritis Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Psoriatic Arthritis Drugs Market Segment by Type
2.1.1 TNF Inhibitors
2.1.2 PDE4 Inhibitors
2.1.3 Interleukin Blockers
2.1.4 Other
2.2 Global Psoriatic Arthritis Drugs Market Size by Type
2.2.1 Global Psoriatic Arthritis Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Psoriatic Arthritis Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Psoriatic Arthritis Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Psoriatic Arthritis Drugs Market Size by Type
2.3.1 United States Psoriatic Arthritis Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Psoriatic Arthritis Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Psoriatic Arthritis Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Psoriatic Arthritis Drugs Market Segment by Application
3.1.1 Mild Psoriatic Arthritis
3.1.2 Moderate Psoriatic Arthritis
3.1.3 Severe Psoriatic Arthritis
3.2 Global Psoriatic Arthritis Drugs Market Size by Application
3.2.1 Global Psoriatic Arthritis Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Psoriatic Arthritis Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Psoriatic Arthritis Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Psoriatic Arthritis Drugs Market Size by Application
3.3.1 United States Psoriatic Arthritis Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Psoriatic Arthritis Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Psoriatic Arthritis Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Psoriatic Arthritis Drugs Competitor Landscape by Company
4.1 Global Psoriatic Arthritis Drugs Market Size by Company
4.1.1 Top Global Psoriatic Arthritis Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Psoriatic Arthritis Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Psoriatic Arthritis Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Psoriatic Arthritis Drugs Price by Manufacturer (2017-2022)
4.2 Global Psoriatic Arthritis Drugs Concentration Ratio (CR)
4.2.1 Psoriatic Arthritis Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Psoriatic Arthritis Drugs in 2021
4.2.3 Global Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Psoriatic Arthritis Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Psoriatic Arthritis Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Psoriatic Arthritis Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Psoriatic Arthritis Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Psoriatic Arthritis Drugs Market Size by Company
4.5.1 Top Psoriatic Arthritis Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Psoriatic Arthritis Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Psoriatic Arthritis Drugs Sales by Players (2020, 2021 & 2022)
5 Global Psoriatic Arthritis Drugs Market Size by Region
5.1 Global Psoriatic Arthritis Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Psoriatic Arthritis Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Psoriatic Arthritis Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Psoriatic Arthritis Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Psoriatic Arthritis Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Psoriatic Arthritis Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Psoriatic Arthritis Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Psoriatic Arthritis Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Psoriatic Arthritis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Psoriatic Arthritis Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Psoriatic Arthritis Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Psoriatic Arthritis Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Psoriatic Arthritis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Psoriatic Arthritis Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Psoriatic Arthritis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Psoriatic Arthritis Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Psoriatic Arthritis Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbvie
7.1.1 Abbvie Corporation Information
7.1.2 Abbvie Description and Business Overview
7.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbvie Psoriatic Arthritis Drugs Products Offered
7.1.5 Abbvie Recent Development
7.2 Janssen
7.2.1 Janssen Corporation Information
7.2.2 Janssen Description and Business Overview
7.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Janssen Psoriatic Arthritis Drugs Products Offered
7.2.5 Janssen Recent Development
7.3 Amgen
7.3.1 Amgen Corporation Information
7.3.2 Amgen Description and Business Overview
7.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Amgen Psoriatic Arthritis Drugs Products Offered
7.3.5 Amgen Recent Development
7.4 Pfizer
7.4.1 Pfizer Corporation Information
7.4.2 Pfizer Description and Business Overview
7.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Pfizer Psoriatic Arthritis Drugs Products Offered
7.4.5 Pfizer Recent Development
7.5 Eli-Lilly
7.5.1 Eli-Lilly Corporation Information
7.5.2 Eli-Lilly Description and Business Overview
7.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Eli-Lilly Psoriatic Arthritis Drugs Products Offered
7.5.5 Eli-Lilly Recent Development
7.6 Celgene
7.6.1 Celgene Corporation Information
7.6.2 Celgene Description and Business Overview
7.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Celgene Psoriatic Arthritis Drugs Products Offered
7.6.5 Celgene Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Psoriatic Arthritis Drugs Industry Chain Analysis
8.2 Psoriatic Arthritis Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Psoriatic Arthritis Drugs Distributors
8.3 Psoriatic Arthritis Drugs Production Mode & Process
8.4 Psoriatic Arthritis Drugs Sales and Marketing
8.4.1 Psoriatic Arthritis Drugs Sales Channels
8.4.2 Psoriatic Arthritis Drugs Distributors
8.5 Psoriatic Arthritis Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
